While it remains unclear whether this peculiarity is due to DR5 splice variants or not [369], DR5 is found to be overexpressed in several cancer types and this overexpression is often associated with tumour aggressiveness and poor patient prognosis [370]. This evidence concerns the gene TNFRSF10B and cancer.